Log in

Relevant bibliographies by topics / Disease prevention / Journal articles

To see the other types of publications on this topic, follow the link: Disease prevention.

Journal articles on the topic 'Disease prevention'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Disease prevention.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Shakhnoza, Iskandarova, and Amilova Asalya. "PREVENTION OF CORONARY HEART DISEASE." American Journal of Medical Sciences and Pharmaceutical Research 04, no. 04 (2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Full text

Abstract:

Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.

APA, Harvard, Vancouver, ISO, and other styles

2

&NA;. "DISEASE PREVENTION." American Journal of Nursing 99, no. 8 (1999): 10. http://dx.doi.org/10.1097/00000446-199908000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pignone, Michael P., and Kirsten Bibbins-Domingo. "Disease Prevention." Medical Clinics of North America 101, no. 4 (2017): i. http://dx.doi.org/10.1016/s0025-7125(17)30070-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Shubrook, Jay H. "Disease prevention." Osteopathic Family Physician 3, no. 5 (2011): 181. http://dx.doi.org/10.1016/j.osfp.2011.07.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Selby, JoeV. "DISEASE PREVENTION." Lancet 341, no. 8847 (1993): 728–29. http://dx.doi.org/10.1016/0140-6736(93)90493-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

SCHAPIRA, DAVID V. "Disease Prevention." Archives of Internal Medicine 149, no. 6 (1989): 1253. http://dx.doi.org/10.1001/archinte.1989.00390060007001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Akhtar, Muhammad Shoaib. "Role of Epidemiological Studies in Disease Prevention." International Journal of Frontier Sciences 3, no. 1 (2019): 1–2. https://doi.org/10.5281/zenodo.2544058.

Full text

Abstract:

Today’s society is full of disease that are of different natures including genetic, infectious and metabolic etc. Every disease has its own mechanisms of affecting humans and different prevention mechanisms as per disease nature. These factors are included in epidemiology of disease. Other factors include prevalence and incidence of diseases in different populations. Exactly knowing about disease epidemiology helps governing authorities to prevent the disease. Unfortunately, under-developed and developing nations are not focusing on diseases epidemiology. On the other hand, all developin

APA, Harvard, Vancouver, ISO, and other styles

8

Turayev, Adkham Abdulfayiz o'g'li Anorov Zoir Abdujabbor oʻgʻli Ibragimov Farkhod Bozor oʻgli Sayidova Zaynura Baxriddinovna. "LIVER ACTIVITY, DISEASES AND DISEASE PREVENTION." "Science and innovation" international scientific journal 1, no. 2 (2022): 64–66. https://doi.org/10.5281/zenodo.6551283.

Full text

Abstract:

The article focuses on the liver, one of the internal organs of living organisms. The liver is one of the largest organisms in the body. It helps digest food, synthesizes the energy needed for life, and removes toxins from the body. The liver plays an important role in the production of bile, digestion and blood. In doing so, the liver uses a protected product to neutralize toxins that are formed or added to the food. If the liver fails, it will inevitably lead to death.

APA, Harvard, Vancouver, ISO, and other styles

9

Zuo, Tongzhuo. "The Current Status of Occupational Disease Prevention." Learning & Education 9, no. 2 (2020): 6. http://dx.doi.org/10.18282/l-e.v9i2.1385.

Full text

Abstract:

Occupational diseases are disorders of health resulting from conditions related to the workplace. There are 2.3 million deaths annually for reasons attributed to work globally, primarily to chemicals or dust. China has the largest working population in the world, with 776 million employed in 2018. According to the National Health Commission, about 12 million companies were found to have occupational-disease-inductive factors and at least 200 million people are exposed to occupational disease hazards. Preventing occupational diseases is a serious worldwide challenge. On the other hand, many dev

APA, Harvard, Vancouver, ISO, and other styles

10

Gitirana, José Valdeci Almeida, Rosa Maria Batista Pinheiro da Fonseca, Fábio Marmentini Piloneto, Luis Felipe Gaia Bevilaqua, Ingrid de Assis, and Ronald de Oliveira Cardoso. "Health education for disease prevention: a review of the literature." Núcleo do Conhecimento 08, no. 11 (2021): 134–47. https://doi.org/10.32749/nucleodoconhecimento.com.br/health/education-for-disease.

Full text

Abstract:

Currently public policies, government actions and different programs involving Health Education (HE) are carried out in favor of population health. With regard to the theme of HE, this is a multifaceted theme, convergent to various personal conceptions, whether in the area of education or health, which may result in divergent understandings. Due to the complexity of the theme, the problem occurs due to the lack of understanding of what is really population-facing HE, dissolving the importance of HE for preventive measures against different diseases, which generates a high budgetary cost in pub

APA, Harvard, Vancouver, ISO, and other styles

11

Pawar, Neha madhukar, and Archana Kulkarni. "CONCEPT OF VYADHIKSHAMATVA IN AYRVEDA." International Journal of Research -GRANTHAALAYAH 8, no. 8 (2020): 239–43. http://dx.doi.org/10.29121/granthaalayah.v8.i8.2020.1064.

Full text

Abstract:

For prevention of diseases, Ayurveda had advocated the adherence to concepts like dina charya, ritu charya, sadvritta , Na vega dharan etc. these measures are useful in preventing the lifestyle related diseases but for preventing the Aupsargik rogas (communicable diseases), Janapada dhwansa rogas (epidemic diseases), Krumij Roga (Infectious diseases), Asatmyaj roga (allergic disorders), the concept of Vyadhikshamtva (Immunity) is propagated by the Ayurvedic science [1]. According to the concept of Ojas or Vyadhikshamatva or Bala (immunity), the body‟s resistance is of tremendous importance in

APA, Harvard, Vancouver, ISO, and other styles

12

Jang, Cheol Yeung, Ji Young Lee, and Hye Kyung Oh. "Infectious Disease Prevention and Evaluation Indicators’ Development of Local Government." Taegu Science University Defense Security Institute 8, no. 4 (2024): 19–29. http://dx.doi.org/10.37181/jscs.2024.8.4.019.

Full text

Abstract:

The purpose of this study is to consistently secure infectious disease policy goals through analysis of the central government's main policy directions and local government work analysis in the field of infectious diseases, and to develop indicators that local governments can implement. Specifically, the goal is to develop a new evaluation system and evaluation indicators for the infectious disease prevention and control work performed by the Korea Disease Control and Prevention Agency and local governments through analysis of the current status of infectious disease response management by loc

APA, Harvard, Vancouver, ISO, and other styles

13

Pipe, Andrew. "Cardiovascular disease prevention." Current Opinion in Cardiology 33, no. 5 (2018): 498–99. http://dx.doi.org/10.1097/hco.0000000000000551.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Van Camp, G. "Cardiovascular disease prevention." Acta Clinica Belgica 69, no. 6 (2014): 407–11. http://dx.doi.org/10.1179/2295333714y.0000000069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Schargrodsky, Herman, María C. Escobar, and Edgardo Escobar. "Cardiovascular Disease Prevention." Circulation 98, no. 20 (1998): 2103–4. http://dx.doi.org/10.1161/01.cir.98.20.2103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Rendall, G. "Bee disease prevention." Veterinary Record 122, no. 13 (1988): 311–12. http://dx.doi.org/10.1136/vr.122.13.311.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Kapustin, Jane. "Chronic Disease Prevention." Journal for Nurse Practitioners 6, no. 1 (2010): 6. http://dx.doi.org/10.1016/j.nurpra.2009.09.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Keevil, Jon G., James H. Stein, and Patrick E. McBride. "Cardiovascular disease prevention." Primary Care: Clinics in Office Practice 29, no. 3 (2002): 667–96. http://dx.doi.org/10.1016/s0095-4543(02)00012-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Burns, Jackie. "Pneumococcal disease prevention." Primary Health Care 12, no. 8 (2002): 24–26. http://dx.doi.org/10.7748/phc.12.8.24.s21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Dietz, William H., Clifford E. Douglas, and Ross C. Brownson. "Chronic Disease Prevention." JAMA 316, no. 16 (2016): 1645. http://dx.doi.org/10.1001/jama.2016.14370.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Maeda, Kazuo. "Prevention of Choriocarcinoma after Postmolar Persistent Trophoblastic Disease." Women Health Care and Issues 2, no. 2 (2019): 01. http://dx.doi.org/10.31579/2642-9756/009.

Full text

Abstract:

Also Chemotherapy was progresses in choriocarcinoma after Methotrexate, still its prevention with the treatment of persistent trophoblastic dusase is needed after molar treatment.The prevention was achieved with particular MTX treatment of persistenttrophoblastic disease.

APA, Harvard, Vancouver, ISO, and other styles

22

Aslam, Dr Imran, Yuldashev Soatboy Jiyanboyevich, and Abdurakhmanova Zamira Ergashboevna. "Prevention & Treatment Of Cardiovascular Diseases." American Journal of Medical Sciences and Pharmaceutical Research 03, no. 06 (2021): 180–88. http://dx.doi.org/10.37547/tajmspr/volume03issue06-28.

Full text

Abstract:

Cardiovascular disease is a significant problem that humans have always faced, affecting thousands of people's lives and health and taking the lives of many people. Many medical institutions and researchers have regarded it as a significant problem in overcoming the cardiovascular disease.1 Much attention has been paid, so the prevention and treatment level in this area has also been rapidly improved. However, cardiovascular disease still cannot be prevented or treated fundamentally, and it is still a significant danger to human health. All people still hope for breakthrough results in cardiov

APA, Harvard, Vancouver, ISO, and other styles

23

Mirzakarimova, Farida, Svetlana Kaleda, Natalia Polikarpova, and Abdumurad Babadjanov. "NONALCOHOLIC FATTY LIVER DISEASE -SOME ASPECTS OF PREVENTION." UZBEK MEDICAL JOURNAL 2, no. 2 (2021): 15–24. http://dx.doi.org/10.26739/2181-0664-2021-2-3.

Full text

Abstract:

Nowadays, NAFLD is considered one of the leading causes of chronic liver diseases globally.This is probably becausea patient with NAFLD usually had more severe diseases -diabetes mellitus type 2 (DM-2), metabolic syndrome, etc. On the one hand, after it was established that insulin resistance underlies these metabolic diseases and, on the other hand, that compensationfor these conditions does not eliminate NAFLD, and the presence of NAFLD worsens the course of the underlying disease, interest in its study increased significantly. The development of NAFLD is increasingly associated with the hyp

APA, Harvard, Vancouver, ISO, and other styles

24

Turner, Chris. "Prevention, prevention." Faculty Dental Journal 10, no. 3 (2019): 94–97. http://dx.doi.org/10.1308/rcsfdj.2019.94.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Najmitdinovna, Kudratova Gulsara, and Ibragimova Yulduz Botyrovna. "PREVENTION OF BRONCHIAL ASTHMA IN CHILDREN AND TEENAGERS." American Journal Of Biomedical Science & Pharmaceutical Innovation 4, no. 3 (2024): 52–55. http://dx.doi.org/10.37547/ajbspi/volume04issue03-07.

Full text

Abstract:

Bronchial asthma is considered a chronic disease and causes many health problems for the population. The disease is based on a genetic predisposition. Children whose parents have allergic diseases (bronchial asthma, allergic rhinitis, atopic dermatitis, eczema, Quincke's edema, etc.) have asthma in the first year of life the tendency to develop the disease is high. (25% if father or mother is sick with allergic diseases, 50% if allergic diseases are observed in both father and mother).

APA, Harvard, Vancouver, ISO, and other styles

26

Dmochowski, Tymon. "Green infrastructure as a disease prevention and rehabilitation tool." Przegląd Naukowy Inżynieria i Kształtowanie Środowiska 28, no. 4 (2019): 682–89. http://dx.doi.org/10.22630/pniks.2019.28.4.61.

Full text

Abstract:

This article tackles with the problem of preventing diseases caused by physical inactivity. It offers a brief review of deadliest diseases and defi nes critical role of green public spaces in their prevention. Article presents patient treatment costs, in contrast to the costs of organizing green public spaces, suggesting substantial relief from economic burden sustained by national health fund by offering green public spaces designed specifi cally for disease prevention instead of conventional treatment.

APA, Harvard, Vancouver, ISO, and other styles

27

Fugh-Berman, A., and S. Epstein. "Tamoxifen: disease prevention or disease substitution?" Lancet 340, no. 8828 (1992): 1143–45. http://dx.doi.org/10.1016/0140-6736(92)93161-f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Berra, K., N. Houston Miller, and J. M. Fair. "Cardiovascular Disease Prevention and Disease Management." Journal of Cardiopulmonary Rehabilitation 26, no. 4 (2006): 197–206. http://dx.doi.org/10.1097/00008483-200607000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Vakrilova Becheva, Maria Stamova, Angelina Georgieva Kirkova-Bogdanova, Stefka Аchkova Ivanova, Petar Jordanov Atanasov, Mariya Sevdelinova Chaneva, and Valentina Boyanova Petkova. "Prevention of cardiovascular diseases." Pharmacia 70, no. 4 (2023): 1243–47. http://dx.doi.org/10.3897/pharmacia.70.e114071.

Full text

Abstract:

Cardiovascular diseases (CVD) are socially significant diseases due to high morbidity and loss of people of working age. In Bulgaria, they are the leading cause of mortality among the population and are a consequence of the effect of cardiovascular risk factors. The draft of the National Health Strategy (NHS) 2021–2030 reports on their wide distribution, as well as on the insufficient knowledge, skills and motivation for their prevention and control. The purpose of this review is to address the prevention of cardiovascular disease, which is a significant problem worldwide. Prevention goals for

APA, Harvard, Vancouver, ISO, and other styles

30

Vakrilova, Becheva Maria Stamova, Angelina Georgieva Kirkova-Bogdanova, Stefka Аchkova Ivanova, Petar Jordanov Atanasov, Mariya Sevdelinova Chaneva, and Valentina Boyanova Petkova. "Prevention of cardiovascular diseases." Pharmacia 70, no. (4) (2023): 1243–47. https://doi.org/10.3897/pharmacia.70.e114071.

Full text

Abstract:

Cardiovascular diseases (CVD) are socially significant diseases due to high morbidity and loss of people of working age. In Bulgaria, they are the leading cause of mortality among the population and are a consequence of the effect of cardiovascular risk factors. The draft of the National Health Strategy (NHS) 2021–2030 reports on their wide distribution, as well as on the insufficient knowledge, skills and motivation for their prevention and control. The purpose of this review is to address the prevention of cardiovascular disease, which is a significant problem worldwide. Prevention goals for

APA, Harvard, Vancouver, ISO, and other styles

31

O'g'li, Roxibjonov Adhamjon Raxmatjon. "PREVENTION OF DILATED CARDIOMYOPATHY DISEASE MEASURES TO TREAT IT." International Journal of Medical Sciences And Clinical Research 3, no. 12 (2023): 13–18. http://dx.doi.org/10.37547/ijmscr/volume03issue12-03.

Full text

Abstract:

Dilated cardiomyopathy is myocardial dysfunction causing heart failure in which ventricular dilation and systolic dysfunction predominate. Symptoms include dyspnea, fatigue, and peripheral edema. Diagnosis is clinical and by elevated natriuretic peptides, chest x-ray, echocardiography, and MRI. Treatment is directed at the cause. If heart failure is progressive and severe, cardiac resynchronization therapy, implantable cardioverter-defibrillator, repair of moderate to severe valvular regurgitation, left ventricular assist device, or heart transplantation may be needed.

APA, Harvard, Vancouver, ISO, and other styles

32

Herman, Herman, Gufran Darma Dirawan, Muhammad Yahya, and Mushawwir Taiyeb. "The Community Disease Prevention Behaviors in District Maros South Sulawesi Province." International Education Studies 8, no. 11 (2015): 104. http://dx.doi.org/10.5539/ies.v8n11p104.

Full text

Abstract:

<p class="apa">The community diseases prevention behaviors assumed influenced by knowledge of infectious disease, hygiene and health knowledge, motivation and of behaviors aof disese prevention than influence by attitude prevention of infectious diseases. This study aimed to examine the effect of variable knowledge infectious disease, hygiene and health knowledge, motivation prevention of infectious diseases, an attitude towards the behavior of infectious disease prevention. The research was conducted in Maros Regency, South Sulawesi Province with a quantitative approach survey method, w

APA, Harvard, Vancouver, ISO, and other styles

33

Gulnara, Asadova, and Djamalov Abdurakhman. "REMEDIES AND RECOMMENDATIONS CORONARY HEART DISEASES." Eurasian Journal of Medical and Natural Sciences 03, no. 02 (2023): 224–28. http://dx.doi.org/10.37547/ejmns-v03-i02-p1-37.

Full text

Abstract:

Prevention of coronary heart disease is a series of complex measures aimed at preventing the onset of the disease, the development and occurrence of possible (predictable) complications, which can be even fatal. Prevention of coronary heart disease is indicated for both sick people and healthy people who are at risk of developing the disease. Patients diagnosed with coronary heart disease are shown non-drug treatment, which is a complete or partial elimination of risk factors. Risk factors are any predisposing factors that increase the likelihood of developing or worsening a disease. Risk fact

APA, Harvard, Vancouver, ISO, and other styles

34

Herawati, Erna, and Yulia Sofiatin. "Socio-cultural aspects of non-communicable disease prevention in three villages in the West Java." Masyarakat, Kebudayaan dan Politik 34, no. 3 (2021): 340. http://dx.doi.org/10.20473/mkp.v34i32021.340-354.

Full text

Abstract:

Community responses to disease, including non-communicable diseases, are influenced by the socio-cultural system. The system shapes community knowledge and belief on diseases, as well as community attitude and practice towards prevention and treatment. Drawing on the case in West Java Province, this study aims at identifying socio-cultural aspects in preventing non-communicable diseases. This study was conducted by using a qualitative design. The data were collected through in-depth interviews and archival study. This study found four socio-cultural aspects related to disease and the preventio

APA, Harvard, Vancouver, ISO, and other styles

35

Chew, Emily Y. "Disease Management by Prevention." Disease Management and Health Outcomes 6, no. 5 (1999): 279–90. http://dx.doi.org/10.2165/00115677-199906050-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Traynor, Kate. "Disease prevention gains attention." American Journal of Health-System Pharmacy 66, no. 15 (2009): 1336–38. http://dx.doi.org/10.2146/news090063.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Lavie, Carl J., Ray W. Squires, and Gerald T. Gau. "Prevention of cardiovascular disease." Postgraduate Medicine 81, no. 5 (1987): 52–72. http://dx.doi.org/10.1080/00325481.1987.11699780.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Tenenbaum, Ariel, Mohammed Morad, and Joav Merrick. "Cardiovascular disease and prevention." International Journal of Adolescent Medicine and Health 26, no. 4 (2014): 457–58. http://dx.doi.org/10.1515/ijamh-2014-0004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Bauer, Michael, and Dominic Coppolo. "Agricultural Lung Disease: Prevention." Seminars in Respiratory and Critical Care Medicine 14, no. 01 (1993): 83–89. http://dx.doi.org/10.1055/s-2007-1006311.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Coralli, Connie. "Disease Prevention/Health Promotion." Nurse Practitioner 15, no. 2 (1990): 74. http://dx.doi.org/10.1097/00006205-199002000-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Gardner, Pierce. "Prevention of Meningococcal Disease." New England Journal of Medicine 355, no. 14 (2006): 1466–73. http://dx.doi.org/10.1056/nejmcp063561.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Kornhuber, J. "Prevention of Alzheimer's Disease." Fortschritte der Neurologie · Psychiatrie 73, no. 6 (2005): 315–16. http://dx.doi.org/10.1055/s-2004-830309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Filley, Christopher M. "Alzheimer disease prevention: Table." Neurology: Clinical Practice 5, no. 3 (2014): 193–200. http://dx.doi.org/10.1212/cpj.0000000000000108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Zimmerman, Marcia. "Phytochemicals and Disease Prevention." Alternative and Complementary Therapies 1, no. 3 (1995): 154–57. http://dx.doi.org/10.1089/act.1995.1.154.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Szekely, C. A., J. C. S. Breitner, and P. P. Zandi. "Prevention of Alzheimer's disease." International Review of Psychiatry 19, no. 6 (2007): 693–706. http://dx.doi.org/10.1080/09540260701797944.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Thal, Leon J. "Prevention of Alzheimer Disease." Alzheimer Disease & Associated Disorders 20, Supplement 2 (2006): S97—S99. http://dx.doi.org/10.1097/00002093-200607001-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Bloomgarden, Z. T. "Prevention of Cardiovascular Disease." Diabetes Care 30, no. 2 (2007): 423–31. http://dx.doi.org/10.2337/dc07-zb02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

&NA;. "Prevention of heart disease." Inpharma Weekly &NA;, no. 833 (1992): 3. http://dx.doi.org/10.2165/00128413-199208330-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Paixao, Andre R. M., Colby R. Ayers, Jarett D. Berry, James A. de Lemos, and Amit Khera. "Atherosclerotic Cardiovascular Disease Prevention." Circulation: Cardiovascular Quality and Outcomes 7, no. 5 (2014): 778–79. http://dx.doi.org/10.1161/circoutcomes.114.001139.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Holmes, Julia S., Irma E. Arispe, and Ernest Moy. "Heart Disease and Prevention." Medical Care 43, Supplement (2005): I—33—I—41. http://dx.doi.org/10.1097/00005650-200503001-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!